ESMO GI 2024 Insights: Paclitaxel and Ramucirumab in HER2- Advanced GC/GEJC - Ph3 ARMANI Trial | VuMedi

ecancer

ESMO GI 2024 Insights: Paclitaxel and Ramucirumab in HER2- Advanced GC/GEJC - Ph3 ARMANI Trial

By ecancer FEATURING Giovanni Randon

By ecancer FEATURING Giovanni Randon

22 views

July 29, 2024

0 Comments

Login to view comments. Click here to Login